Safety of long-acting beta2-agonists in the treatment of asthma.

Safety of long-acting beta2-agonists in the treatment of asthma.

Item
http://www.wikidata.org/entity/Q37362572
β(2) -adrenoceptor agonists: current and future directionThe Lipid-lowering Effects of R-bambuterol in Healthy Chinese Volunteers: A Randomized Phase I Clinical Study.In vitro effects of Beta-2 agonists on skeletal muscle differentiation, hypertrophy, and atrophy.Efficacy and Safety of Roflumilast in Korean Patients with COPD.The anti-asthma herbal medicine ASHMI acutely inhibits airway smooth muscle contraction via prostaglandin E2 activation of EP2/EP4 receptors.Pharmacotherapy for exercise-induced asthma: allowing normal levels of activity and sport.Long-term safety of nebulized formoterol: results of a twelve-month open-label clinical trial.Efficacy of tiotropium in COPD patients from Asia: a subgroup analysis from the UPLIFT trial.Use and safety of long-acting β2-agonists for pediatric asthma
P2860

Safety of long-acting beta2-agonists in the treatment of asthma.

Item
http://www.wikidata.org/entity/Q37362572
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Safety of long-acting beta2-agonists in the treatment of asthma.
@en
Safety of long-acting beta2-agonists in the treatment of asthma.
@nl
type
label
Safety of long-acting beta2-agonists in the treatment of asthma.
@en
Safety of long-acting beta2-agonists in the treatment of asthma.
@nl
prefLabel
Safety of long-acting beta2-agonists in the treatment of asthma.
@en
Safety of long-acting beta2-agonists in the treatment of asthma.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Safety of long-acting beta2-agonists in the treatment of asthma.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921